Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7343 p384
2 April 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Urine kits urge men to take chlamydia test

Urine samples

A total of 401 urine samples were submitted for analysis during the trial

Offering urine test kits and a streamlined process for accessing treatment are key factors in encouraging young men to be tested for chlamydia, according to the results of a study published this week.

The two-phase project was led by the Men’s Health Forum and funded by the Department of Health, the National Pharmaceutical Association and Roche Diagnostics. The first phase was a qualitative attitudinal study among men aged 18 to 25 years, and revealed that many believe that chlamydia testing involves a painful swab “umbrella test”. Although symptoms are seen in only 50 per cent of chlamydia cases, many of the men questioned said they would only seek help if they experienced symptoms.

The second phase was a chlamydia screening trial that targeted 4,000 young men in Telford, Shropshire. Six local employers provided free chlamydia testing kits to their staff (PJ, 31 July 2004, p138) who, if infected, were able to obtain antibiotics from participating pharmacies under a patient group direction.

There were 401 samples submitted for analysis, with almost 10 per cent of men in the target age range (under 30 years) in the six workplaces choosing to take the test. In total, 3.4 per cent of men under 30 years tested positive for chlamydia. The majority preferred to obtain treatment from their pharmacy.

The full report is available here

Back to Top


©The Pharmaceutical Journal